ASX - By Stock
|
AVR |
Re:
Ann: Proposed issue of securities - AVR
|
|
NCRAW
|
1 |
569 |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1
|
569
|
7
|
|
ASX - By Stock
|
AVR |
Re:
AVR milestones
|
|
NCRAW
|
74 |
32K |
0 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
74
|
32K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Go AVR
|
|
NCRAW
|
6 |
3.1K |
10 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
6
|
3.1K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
NCRAW
|
104 |
44K |
6 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
104
|
44K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
NCRAW
|
140 |
50K |
5 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
140
|
50K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
NCRAW
|
140 |
50K |
8 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
140
|
50K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
|
|
NCRAW
|
140 |
50K |
8 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
140
|
50K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
AVR Options
|
|
NCRAW
|
44 |
10K |
1 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
44
|
10K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR Options
|
|
NCRAW
|
44 |
10K |
3 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
44
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
NCRAW
|
74 |
18K |
2 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
74
|
18K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
NCRAW
|
74 |
18K |
1 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
74
|
18K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Pause in Trading
|
|
NCRAW
|
15 |
3.3K |
0 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
15
|
3.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Expanded Funding Package
|
|
NCRAW
|
38 |
9.2K |
4 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
38
|
9.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Price Predictions - End of Year
|
|
NCRAW
|
90 |
29K |
0 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
90
|
29K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Expanded Funding Package
|
|
NCRAW
|
38 |
9.2K |
5 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
38
|
9.2K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-Calcification Study
|
|
NCRAW
|
107 |
30K |
0 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
107
|
30K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
NCRAW
|
439 |
125K |
3 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
439
|
125K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
NCRAW
|
439 |
125K |
0 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
439
|
125K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
NCRAW
|
439 |
125K |
1 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
439
|
125K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
NCRAW
|
439 |
125K |
3 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
439
|
125K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
NCRAW
|
439 |
125K |
7 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
439
|
125K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
FNN Presentation .. WOW!
|
|
NCRAW
|
160 |
50K |
1 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
160
|
50K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
NCRAW
|
439 |
125K |
15 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
439
|
125K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
FNN Presentation .. WOW!
|
|
NCRAW
|
160 |
50K |
2 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
160
|
50K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
FNN Presentation .. WOW!
|
|
NCRAW
|
160 |
50K |
7 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
160
|
50K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: First in human trial commences
|
|
NCRAW
|
71 |
21K |
0 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
71
|
21K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Approval for first-in-human study
|
|
NCRAW
|
70 |
21K |
0 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
70
|
21K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Investor call being scheduled
|
|
NCRAW
|
61 |
32K |
2 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
61
|
32K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
What are the positives?
|
|
NCRAW
|
65 |
20K |
1 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
65
|
20K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update to LeMaitre Vascular deal
|
|
NCRAW
|
86 |
66K |
0 |
06/01/20 |
06/01/20 |
ASX - By Stock
|
86
|
66K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
First in Human Feasibility Study With ADAPT 3D
|
|
NCRAW
|
53 |
31K |
0 |
03/01/20 |
03/01/20 |
ASX - By Stock
|
53
|
31K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
First in Human Feasibility Study With ADAPT 3D
|
|
NCRAW
|
53 |
31K |
11 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
53
|
31K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
AHZ Revisited
|
|
NCRAW
|
11 |
4.4K |
10 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
11
|
4.4K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Director Appointment/Resignation
|
|
NCRAW
|
177 |
67K |
5 |
05/10/18 |
05/10/18 |
ASX - By Stock
|
177
|
67K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Director Appointment/Resignation
|
|
NCRAW
|
177 |
67K |
9 |
04/10/18 |
04/10/18 |
ASX - By Stock
|
177
|
67K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Secures Strategic Investor
|
|
NCRAW
|
390 |
156K |
6 |
17/09/18 |
17/09/18 |
ASX - By Stock
|
390
|
156K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Secures Strategic Investor
|
|
NCRAW
|
390 |
156K |
3 |
13/09/18 |
13/09/18 |
ASX - By Stock
|
390
|
156K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for voluntary suspension
|
|
NCRAW
|
150 |
51K |
21 |
18/08/18 |
18/08/18 |
ASX - By Stock
|
150
|
51K
|
21
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Voluntary Suspension
|
|
NCRAW
|
155 |
58K |
4 |
07/08/18 |
07/08/18 |
ASX - By Stock
|
155
|
58K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Q2 Adapt results
|
|
NCRAW
|
121 |
49K |
0 |
06/07/18 |
06/07/18 |
ASX - By Stock
|
121
|
49K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Q2 Adapt results
|
|
NCRAW
|
121 |
49K |
0 |
06/07/18 |
06/07/18 |
ASX - By Stock
|
121
|
49K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Share Purchase Plan
|
|
NCRAW
|
30 |
9.4K |
0 |
11/05/18 |
11/05/18 |
ASX - By Stock
|
30
|
9.4K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
NCRAW
|
110 |
33K |
0 |
09/05/18 |
09/05/18 |
ASX - By Stock
|
110
|
33K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
NCRAW
|
110 |
33K |
0 |
08/05/18 |
08/05/18 |
ASX - By Stock
|
110
|
33K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
NCRAW
|
110 |
33K |
2 |
08/05/18 |
08/05/18 |
ASX - By Stock
|
110
|
33K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Letter of intent to fund Vacs
|
|
NCRAW
|
111 |
35K |
4 |
27/04/18 |
27/04/18 |
ASX - By Stock
|
111
|
35K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Sentiment Change
|
|
NCRAW
|
17 |
7.7K |
1 |
26/04/18 |
26/04/18 |
ASX - By Stock
|
17
|
7.7K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Sentiment Change
|
|
NCRAW
|
17 |
7.7K |
3 |
26/04/18 |
26/04/18 |
ASX - By Stock
|
17
|
7.7K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Annual Report to shareholders
|
|
NCRAW
|
49 |
18K |
2 |
20/04/18 |
20/04/18 |
ASX - By Stock
|
49
|
18K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor presentation
|
|
NCRAW
|
123 |
45K |
6 |
19/04/18 |
19/04/18 |
ASX - By Stock
|
123
|
45K
|
6
|
|